| Log in
Photo Credit: Thinkstock

Ipca Labs acquires US drugmaker Pisgah for $9.65 mn

17 January, 2018

Ipca Laboratories has fully acquired American pharmaceutical company Pisgah Labs for $9.65 million, the Mumbai-headquartered drugmaker said in a stock exchange filing on Tuesday.

The acquisition was made via Ipca Labs’ US subsidiaries, Ipca Pharmaceutical Inc and Onyx Scientific Ltd.

In a statement, Ipca Labs said the acquisition would help it establish a foothold in the US market in the fields of contract research, intermediates manufacturing and small-volume active pharmaceutical ingredients (API).

“Pisgah Labs has been a chemistry solutions provider for over three decades and will continue to operate out of its North Carolina manufacturing facility under the Pisgah trade name,” Ipca Labs said in a statement.

Pisgah, which was founded in 1981, had a total income of $2.89 million and earnings before interest, taxation, depreciation and amortisation (EBITDA) of $1.14 million in the previous financial year.

Ipca Labs has previously made several similarly-sized acquisitions, including in the US.

In 2015, the company had acquired 19% stake in Hyderabad-headquartered Krebs Biochemicals & Industries Ltd.

The year before that, the firm had acquired a manufacturing plant in Indore from Alpa Labs for Rs 71.71crore ($12 million at the time).

Founded more than six decades ago, Ipca Labs manufactures APIs and finished dosage forms. It has a significant presence in domestic branded formulations, global branded and generic formulations, and global APIs.

Ipca’s investors include India-focused private equity firm Chrys Capital and Malaysian sovereign wealth fund Khazanah.

The company reported revenues of Rs 3,156 crore for the financial year 2016-17. Close to 40% of its revenue comes from exports.

Ipca’s share price stood at Rs 584.60 at the close of trade on Wednesday, up 1.9% from its previous close. The BSE Sensex rose 0.89% on Wednesday as it hit the 35,000 mark for the first time.

Like this report? Sign up for our daily newsletter to get our top reports.


Leave Your Comment
Pharma Co Ipca Labs Acquires UK-based Onyx Research Chem For Rs 34Cr

Pharma Co Ipca Labs Acquires UK-based Onyx Research Chem For Rs 34Cr

TEAM VCC 7 years ago
Mumbai-based pharmaceutical company Ipca Laboratories Ltd has acquired 100 per...
Ipca Labs partners with US-based Oncobiologics to manufacture biosimilars

Ipca Labs partners with US-based Oncobiologics to manufacture biosimilars

TEAM VCC 4 years ago
Mumbai-based Ipca Laboratories Ltd, which manufactures active pharmaceutical...
Ipca Labs picks 19% stake in Krebs Biochem, hiking it to 30%; makes open offer

Ipca Labs picks 19% stake in Krebs Biochem, hiking it to 30%; makes open offer

Jasleen Kaur Batra 3 years ago
Mumbai-based Ipca Laboratories Ltd, which manufactures active pharmaceutical...
No Comments

Ipca Labs acquires US drugmaker Pisgah for $9.65 mn

Powered by WordPress.com VIP